Messages in brief
Herbal medicinal products: Directive 2004/24/EC
The background to the recent discussions is not a 'new' document from the European Commission, but the 2004 Directive 2004/24 EC, which defines…
Information on vaccination incidents in Japan
Prevenar (active ingredient: pneumococcal polysaccharides of serotype 4, 6B, 9V, 14, 18C, 19F and 23F, conjugated to CRM197 carrier protein, adsorbed)…
Clinical Trials
Marketing Authorisation & Lifecycle Management
Deadline according to the Medicines Act
At the end of 2010, the following deadlines will expire according to the Medicines Act BGBl Nr 185/1983 as amended:
Inclusion of doping warning…
Agreement between Austria and Liechtenstein
As of 01.12.2010, the agreement between the Republic of Austria and the Government of the Principality of Liechtenstein concerning the automatic…
Directive 2004/24/EC: List of medicinal products
- Table 1: Product on the market and new application filed (65)*.
- Table 2: Product not on the market, new application filed (6)**
- Table 3: Product…
Directive 2004/24/EC for traditional herbal medicinal products
Due to a given occasion and due to inquiries regarding "innovations" in the field of traditional herbal medicinal products, the Federal Office for…
Conversion of the AGES PharmMed pharmacovigilance database
BASG/AGES PharmMed informs about the internal changeover of the E2B transmission of individual case reports, which was previously done via WebTrader,…
eService-Plattform online
All eServices offered by BASG / AGES PharmMed will be available via this platform in the future. Currently, the following services can be accessed via…
